Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on FERREXPO PLC. We currently have 6 research reports from 2 professional analysts.
|28Nov16 07:00||RNS||Board Announcements|
|31Oct16 07:00||RNS||Holding(s) in Company|
|05Oct16 07:00||RNS||3Q production report|
|15Sep16 05:38||RNS||Director/PDMR Shareholding|
|14Sep16 05:43||RNS||Director/PDMR Shareholding|
|12Sep16 06:17||RNS||Results of General Meeting|
|15Aug16 04:24||RNS||Notice of GM|
Frequency of research reports
Research reports on
Golden opportunity in Western Australia’s Goldfields region
17 Nov 15
Ferrex, a diversified mineral resource development company, has entered into an agreement to acquire 100% of Chaffers Mining, a private Australian gold company. Chaffers currently has a five year toll milling agreement in place with Norton Goldfields to mine certain defined gold deposits on Norton’s mining leases, located 30km north of Kalgoorlie in Western Australia. Ore will be treated through Norton’s nearby Paddington processing plant. The gold deposits host historical resources of 5.7Mt grading 2g/t containing 364koz gold and located within 25km of the Paddington plant. Under terms of the acquisition, Ferrex will issue £465,000 in shares at a deemed price of 0.5p to acquire 100% of Chaffers and an additional £465,000 in shares on production of 10,000oz of gold (equivalent to an in-situ value, on aggregate, of US$3.9/oz historical resource at current prices). In addition, Ferrex will pay all processing costs and a 22% royalty to Norton on any gold recovered.
Developing Mineral Assets: near term production potential in Africa
25 Feb 15
The Company is currently concentrating on the Nayega Mn Project in Togo because of its potential for near-term cash flow. The Company still expects to conclude the Mining Convention by the end of Q1 2015 at Nayega. It is in the interests of shareholders for the Company to concentrate on Nayega. The Mining Convention approval is without doubt a short-term catalyst for value enhancement, and its approval could attract interest from potential partners. Management demonstrates support with their shareholding, their previous track record and 11,250,000 shares being subscribed by each of the Chairman and Managing Director.
30 Nov 16
Abzena (ABZA): Interim results indicate happy customers (BUY) | Horizonte Minerals* (HZM): Fund raise completed (CORP) | SacOil* (SAC): Half-year trading statement (CORP) | Revolution Bars (RBG): New openings (BUY) | Amino Technologies* (AMO): Multi operator FUSION roll out (CORP)
Small Cap Breakfast
29 Nov 16
Asia Pacific Investment Partner - the research-driven emerging and frontier markets real estate development business intends to float on AIM and conduct a placing in December RM Secured Direct Lending - The secured direct lending fund intends to float on the Main Market on 15 December raising up to £100m Diversified Oil & Gas— Schedule One now out. $60m to be raised. Expected admission 6 December. Creo Medical Group —UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.
24 Nov 16
Quixant* (QXT): Gaming gains (CORP) | SCISYS* (SSY): Bringing good news from Germany (CORP) | Hayward Tyler Group*: Contract wins (CORP) | Sound Energy (SOU): TE-7 flow rate and fund raise (BUY) | Water Intelligence* (WATR): Growth and improving returns in a defensive market (CORP) | Imaginatik* (IMTK): Interim trading update (CORP)
High grade, low cost gold
28 Nov 16
High grades and low costs mean that, in our view, Scotgold’s Cononish project could generate more than £14m a year in EBITDA. In addition to advancing funding discussions based on the compelling bankable feasibility study mine plan (which at £950/oz gold price and 8% WACC gives a project NPV of £43.0m), the company is exploring optimisation opportunities, as well as the potential for a phased approach requiring lower up front capital. We are resuming coverage with a Buy recommendation and target price of 2.2p